Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults

Cited by (277)

Items 101–200 of 277

1. Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells
   Sheila González-Salvatierra, Cristina García‐Fontana, Jesús Lacal, Francisco Andújar-Vera, Luis Martínez-Heredia, Raquel Sanabria-de la Torre, María Ferrer-Millán, Enrique Moratalla-Aranda, Manuel Muñoz‐Torres, Beatriz García-Fontana · 2023 · Cardiovascular Diabetology
2. High doses of vitamin C plus E reduce strength training-induced improvements in areal bone mineral density in elderly men
   Astrid Kamilla Stunes, Unni Syversen, Sveinung Berntsen, Gøran Paulsen, Tonje Holte Stea, Ken J. Hetlelid, Hilde Lohne‐Seiler, Mats Peder Mosti, Thomas Bjørnsen, Truls Raastad et al. · 2017 · European Journal of Applied Physiology
3. Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation
   Lida Tartaglione, Marzia Pasquali, Silverio Rotondi, Maria Luisa Muci, Cristiana Leonangeli, Alessio Farcomeni, Valeria Fassino, Sandro Mazzaferro · 2017 · PLoS ONE
4. Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease
   Michelle Maree McDonald, Jesús Delgado‐Calle · 2017 · Current Osteoporosis Reports
5. Computational and functional characterization of four SNPs in the SOST locus associated with osteoporosis
   Weiyuan Ye, Ya Wang, Bing Mei, Sasa Hou, Xinhong Liu, Guiju Wu, Longjuan Qin, Kehui Zhao, Qingyang Huang · 2018 · Bone
6. Expression of Fibroblast Growth Factor 23, Vitamin D Receptor, and Sclerostin in Bone Tissue from Hypercalciuric Stone Formers
   Viviane Barcellos Menon, Rosa Maria Affonso Moysés, Samirah Abreu Gomes, Aluízio Barbosa Carvalho, Vanda Jorgetti, Ita Pfeferman Heilberg · 2014 · Clinical Journal of the American Society of Nephrology
7. Negative Association Between Sclerostin and INSL3 in Isolated Human Osteocytes and in Klinefelter Syndrome: New Hints for Testis–Bone Crosstalk
   Andrea Di Nisio, Luca De Toni, Maria Santa Rocca, Marco Ghezzi, Riccardo Selice, Giuseppe Taglialavoro, Alberto Ferlin, Carlo Foresta · 2018 · The Journal of Clinical Endocrinology & Metabolism
8. Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
   Antonia Boman, Heidi Kokkonen, Lisbeth Ärlestig, Ewa H. Berglin, Solbritt Rantapää‐Dahlqvist · 2017 · Clinical Rheumatology
9. Determinants of bone mass in older adults with normal- and overweight derived from the crosstalk with muscle and adipose tissue
   Carina O. Walowski, Catrin Herpich, Janna Enderle, Wiebke Braun, Marcus Both, Mario Hasler, Manfred James Müller, Kristina Norman, Anja Bosy‐Westphal · 2023 · Scientific Reports
10. Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis
    Kristyna Brabnikova Maresova, Kateřina Jarošová, Karel Pavelká, Jan J. Stepan · 2014 · Arthritis Research & Therapy
11. Cell–cell communication in bone development and whole-body homeostasis and pharmacological avenues for bone disorders
    Young Eun Park, David S. Musson, Dorit Naot, Jillian Cornish · 2017 · Current Opinion in Pharmacology
12. Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
    Henrik Boltenstål, Abdul Rashid Qureshi, Geert J. S. Behets, Bengt Lindholm, Peter Stenvinkel, Patrick C. D’Haese, Mathias Loberg Haarhaus · 2018 · Calcified Tissue International
13. Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease
    Annelies De Maré, Anja Verhulst, Etienne Cavalier, Pierre Delanaye, Geert J. S. Behets, Björn K.I. Meijers, Dirk R. J. Kuypers, Patrick C. D’Haese, Pieter Evenepoel · 2019 · Journal of Clinical Medicine
14. Sclerostin levels predict cardiovascular mortality in long-term hemodialysis patients: A prospective observational cohort study
    Marta Kalousová, S Sulková, Aleš Antonín Kuběna, Oskar Zakiyanov, Vladimı́r Tesař, Tomáš Zima · 2019 · Physiological Research
15. Bone metabolism in patients with anorexia nervosa and amenorrhoea
    Luca Idolazzi, Marwan El Ghoch, Riccardo Dalle Grave, Paola Vittoria Bazzani, Simona Calugi, Stefania Fassio, Cristian Caimmi, Ombretta Viapiana, Francesco Bertoldo, V. Braga et al. · 2016 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
16. Endocrine functions of sclerostin
    Ryan C. Riddle · 2022 · Current Opinion in Endocrine and Metabolic Research
17. Exercise does not enhance aged bone's impaired response to artificial loading in C57Bl/6 mice
    Lee B. Meakin, Chinedu Theresa Udeh‐Momoh, Gabriel L. Galea, Lance E. Lanyon, J. S. Price · 2015 · Bone
18. The relationship between postmenopausal women’s sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products
    Müberra Namlι Kalem, Ziya Kalem, Nilüfer Akgün, Batuhan Bakırarar · 2017 · Archives of Gynecology and Obstetrics
19. Sclerostin and Its Associations With Bone Metabolism Markers and Sex Hormones in Healthy Community-Dwelling Elderly Individuals and Adolescents
    Yang Xu, Chao Gao, Jin‐Wei He, Wenqin Gu, Chuntao Yi, Bihua Chen, Qingqing Wang, Feng Ru Tang, Ju-Liang Xu, Hua Yue et al. · 2020 · Frontiers in Cell and Developmental Biology
20. Sclerostin
    Mahalakshmi Honasoge, Ajay Dhanwada Rao, Sudhaker D. Rao · 2014 · Current Opinion in Endocrinology Diabetes and Obesity
21. Dickkopf-1 and Sclerostin Serum Levels in Patients with Systemic Mastocytosis
    Maurizio Rossini, Ombretta Viapiana, Roberta Zanotti, Gaia Tripi, Omar Perbellini, Luca Idolazzi, Massimiliano Bonifacio, Silvano Adami, Davide Gatti · 2015 · Calcified Tissue International
22. Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy
    Josivan Gomes Lima, Lúcia Helena Coelho Nóbrega, Natália Nóbrega de Lima, Marcel Catão Ferreira dos Santos, Maria de Fátima Paiva Baracho, Renaud Winzenrieth, Francisco Alfredo Farias Bandeira, Carolina de Oliveira Mendes-Aguiar, Francisco Paulo Freire Neto, Leonardo Capistrano Ferreira et al. · 2017 · Bone
23. Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths
    Stefano Mora, Maria Puzzovio, Vania Giacomet, Valentina Fabiano, Katia Maruca, Silvia Capelli, Pilar Nannini, Giovanni Lombardi, Gianvincenzo Zuccotti · 2015 · Endocrine
24. Sclerostin and bone strength in women in their 10th decade of life
    Sara Thorson, Tanushree Prasad, Yahtyng Sheu, Michelle E. Danielson, Aarthi Arasu, Steven Ron Cummings, Jane A. Cauley · 2013 · Journal of Bone and Mineral Research
25. Sclerostin Immunoreactivity Increases in Cortical Bone Osteocytes and Decreases in Articular Cartilage Chondrocytes in Aging Mice
    Michelle L. Thompson, Juan Miguel Jiménez‐Andrade, Patrick W. Mantyh · 2015 · Journal of Histochemistry & Cytochemistry
26. Sclerostin in Institutionalized Elderly Women: Associations with Quantitative Bone Ultrasound, Bone Turnover, Fractures, and Mortality
    Karin Amrein, Harald Dobnig, Doris Wagner, Claudia Piswanger-Soelkner, Thomas Rudolf Pieber, Stefan Pilz, Andreas Tomaschitz, Hans Peter Dimai, Astrid Fahrleitner‐Pammer · 2014 · Journal of the American Geriatrics Society
27. Serum sclerostin concentration is associated with specific adipose, muscle and bone tissue markers in lean adolescent females with increased physical activity
    Jaak Jürimäe, Vita Karvelyte, Liina Remmel, Anna‐Liisa Tamm, Priit Purge, Rita Gruodytė-Račienė, Sigitas Kamandulis, Katre Maasalu, Luis Gracia‐Marco, Vallo Tillmann · 2021 · Journal of Pediatric Endocrinology and Metabolism
28. Serum Sclerostin Levels Are Decreased in Adult Patients With Different Types of Osteogenesis Imperfecta
    Roland Kocijan, Christian Muschitz, Astrid Fahrleitner‐Pammer, Karin Amrein, Peter Pietschmann, Judith Haschka, Sebastian Dinu, Stylianos Kapiotis, Heinrich Resch · 2013 · The Journal of Clinical Endocrinology & Metabolism
29. Sclerostin as a novel marker of bone turnover in athletes
    Aleksandra Zagrodna, Paweł Jóźków, Marek Mędraś, M Majda, Małgorzata Renata Słowińska-Lisowska · 2016 · Biology of Sport
30. Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy
    Lindsey E. Nicol, Ying Wang, Rosamund C. Smith, John H. Sloan, Sandesh C.S. Nagamani, Jay Robert Shapiro, Brendan Lee, ERIC S. ORWOLL · 2017 · Journal of Bone and Mineral Research
31. Sclerostin: clinical insights in muscle–bone crosstalk
    Antimo Moretti, Giovanni Iolascon · 2023 · Journal of International Medical Research
32. Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
    Elżbieta Skowrońska‐Jóźwiak, Kinga Krawczyk‐Rusiecka, Krzysztof Cezary Lewandowski, Zbigniew Adamczewski, Andrzej Lewiñski · 2012 · Thyroid Research
33. Serum sclerostin is negatively associated with insulin sensitivity in obese but not lean women
    Anouar Aznou, Rick I. Meijer, Daniël H. van Raalte, Martin den Heijer, Annemieke C. Heijboer, Renate T. de Jongh · 2021 · Endocrine Connections
34. Subcutaneous adipose tissue sclerostin is reduced and Wnt signaling is enhanced following 4‐weeks of sprint interval training in young men with obesity
    Nigel Kurgan, Hashim Islam, Jennifer B. L. Matusiak, Bradley J. Baranowski, Joshua Stoikos, Val Andrew Fajardo, Rebecca E. K. MacPherson, Brendon J. Gurd, Panagiota Klentrou · 2022 · Physiological Reports
35. Sclerostin Declines during Hemodialysis and Appears in Dialysate
    Bernhard O. Bielesz, Till Hempfing, Heidi Kieweg, Rodrig Marculescu, Martin Haas, Daniel Cejka · 2014 · Blood Purification
36. Ibandronate Increases Sclerostin Levels and Bone Strength in Male Patients with Idiopathic Osteoporosis
    Christian Muschitz, Roland Kocijan, Dieter H. Pahr, Janina Patsch, Karin Amrein, Barbara M. Misof, Alexandra Kaider, Heinrich Resch, Peter Pietschmann · 2015 · Calcified Tissue International
37. Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study
    Marco Atteritano, Ernesto Di Mauro, Valeria Canale, A. Bruzzese, Carlo Alberto Ricciardi, Valeria Cernaro, Antonio Lacquaniti, Michele Buemi, Domenico Santoro · 2016 · Osteoporosis International
38. Sclerostin within the chronic kidney disease spectrum
    Antoine Bouquegneau, Peter Evenepoel, François Paquot, Olivier Malaise, Etienne Cavalier, Pierre Delanaye · 2019 · Clinica Chimica Acta
39. Exercise and Diet: Uncovering Prospective Mediators of Skeletal Fragility in Bone and Marrow Adipose Tissue
    Sarah E Little, Gabriel M. Pagnotti, Cody McGrath, Maya Styner · 2020 · Current Osteoporosis Reports
40. Mechanisms of Normalisation of Bone Metabolism during Recovery from Hyperthyroidism: Potential Role for Sclerostin and Parathyroid Hormone
    Elżbieta Skowrońska‐Jóźwiak, Krzysztof Cezary Lewandowski, Zbigniew Adamczewski, Kinga Krawczyk‐Rusiecka, Andrzej Lewiñski · 2015 · International Journal of Endocrinology
41. Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?
    Cyrille B. Confavreux, Romain Casey, Annie Varennes, J. Goudable, Roland D Chapurlat, Paweł Szulc · 2016 · Osteoporosis International
42. Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis
    Maurizio Rossini, Silvano Adami, Roberta Zanotti, Ombretta Viapiana, Luca Idolazzi, Marta Biondan, Davide Gatti · 2014 · Journal of Allergy and Clinical Immunology
43. Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus
    Sevil Kurban, Beray Selver Eklioğlu, Muhammed Burak Selver · 2022 · Journal of Pediatric Endocrinology and Metabolism
44. Effect of acute resistance exercise on bone turnover in young adults before and after concurrent resistance and interval training
    Kristen J. Koltun, Adam J. Sterczala, Nicole M. Sekel, Kellen T. Krajewski, Brian J. Martin, Mita T. Lovalekar, Christopher Connaboy, Shawn D. Flanagan, Sophie L. Wardle, Thomas J. O’Leary et al. · 2024 · Physiological Reports
45. Factors associated with serum soluble inhibitors of W nt‐β‐catenin signaling (sclerostin and dickkopf‐1) in patients undergoing peritoneal dialysis
    Shunsuke Yamada, Kazuhiko Tsuruya, Masanori Tokumoto, Hisako Yoshida, Hiroaki Ooboshi, Takanari Kitazono · 2015 · Nephrology
46. Bone Mineral Density and Body Composition are Associated with Circulating Angiogenic Factors in Post-menopausal Women
    A. Spangenberg, Negar Maghsoodi, Dwight Dulnoan, Amelia E.B. Moore, Sylvia Frances Edwards, Michelle L. Frost, Geeta Hampson · 2016 · Calcified Tissue International
47. Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study
    Chrysoula G. Liakou, George P. Mastorakos, Konstantinos Makris, Ioannis G. Fatouros, Alexandra A. Avloniti, Helen Marketos, Julia D. Antoniou, Αντώνιος Γαλανός, Ismene A. Dontas, Demetrios Rizos et al. · 2016 · Endocrine
48. Wnt Signaling–Related Osteokines at Rest and Following Plyometric Exercise in Prepubertal and Early Pubertal Boys and Girls
    Panagiota Klentrou, Kirina Angrish, Nafisa Awadia, Nigel Kurgan, Rozalia Kouvelioti, Bareket Falk · 2018 · Pediatric Exercise Science
49. Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus
    Sabaa Salim Joad, Elliot Ballato, Fnu Deepika, Giulia Gregori, Alcibiades Leonardo Fleires-Gutierrez, Georgia Colleluori, Lina E. Aguirre, Rui Chen, Vittoria Russo, Virginia Fuenmayor Lopez et al. · 2021 · Frontiers in Endocrinology
50. A Cross‐Sectional Study to Assess the Modulation of Wnt Inhibitors following Anti‐Epileptic Drug Therapy and their Correlation with Vitamin D and Receptor Activator of Nuclear Factor κ B Ligand in Indian Women with Epilepsy
    Bushra Parveen, Manjari Tripathi, Divya Vohora · 2018 · Basic & Clinical Pharmacology & Toxicology
51. Sclerostin Influences Exercise-Induced Adaptations in Body Composition and White Adipose Tissue Morphology in Male Mice
    Kurgan, Nigel, Stoikos, Joshua, Baranowski, Bradley J., Yumol, Jenalyn, Dhaliwal, Roopan, Sweezey-Munroe, Jake B., Fajardo, Val A., Gittings, William, Macpherson, Rebecca E.K., Klentrou, Panagiota · 2020 · Journal of Bone and Mineral Research
52. Deciphering the potential pharmaceutical mechanism of Guzhi Zengsheng Zhitongwan on rat bone and kidney based on the “kidney governing bone” theory
    Baojin Yao, Jia Liu, Mei Zhang, Xiangyang Leng, Daqing Zhao · 2020 · Journal of Orthopaedic Surgery and Research
53. Serum sclerostin levels in osteoporotic fracture patients
    Erwin A. Gorter, Casper R. Reinders, Pieta Krijnen, Natasha M. Appelman‐Dijkstra, Inger Birgitta Schipper · 2022 · European Journal of Trauma and Emergency Surgery
54. Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial
    Rocky Strollo, Andreea Soare, Yeganeh Manon Khazrai, Antonio Di Mauro, Andrea Palermo, Rossella Del Toro, Sara Fallucca, Maria Giovanna Belluomo, Laura Dugo, Mario Pianesi et al. · 2016 · Endocrine
55. Peroxisome proliferator activated receptor-γ in osteoblasts controls bone formation and fat mass by regulating sclerostin expression
    Soohyun P. Kim, Avery H. Seward, Jean G. Garcia-Diaz, Nathalie S. Alekos, Nicole R. Gould, Susan M. Aja, Joseph P. Stains, Michael J. Wolfgang, Ryan C. Riddle · 2023 · iScience
56. The role of sclerostin in lipid and glucose metabolism disorders
    Hewen Jiang, Dijie Li, Ying Han, Nanxi Li, Xiaohui Tao, Jin Liu, Zongkang Zhang, Yuanyuan Yu, Luyao Wang, Sifan Yu et al. · 2023 · Biochemical Pharmacology
57. Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral Densitometry
    Abdulrahman Y Almansouri, Mohammed E. Abdulfatah, Omar H. Baaqil, Alaa Abdulrahman Bakheet, Sarah Turki, Mamdouh M. Kotb, Alaa Althubaiti, Majed M. Almaghrabi, Abdulrahman M. Althubaiti, Badr Madani et al. · 2016 · Journal of Bone Metabolism
58. Sclerostin and its role as a bone modifying agent in periodontal disease
    Nisha Ashifa, Krishnan Viswanathan, Rajasekar Sundaram, Sivapragasam Srinivasan · 2021 · Journal of Oral Biosciences
59. The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
    Se Hwa Kim, Soo Young Yoon, Sung-Kil Lim, Yumie Rhee · 2014 · International Journal of Endocrinology
60. Application and Effect of Mobiletype-Bone Health Intervention in Korean Young Adult Women with Low Bone Mass: A Randomized Control Trial
    Young Joo Park, Sook-Ja Lee, Nah-Mee Shin, Hyunjeong Shin, Songi Jeon, Jung-Woo Lee, Inhae Cho · 2017 · Asian Nursing Research
61. Viewpoint on the role of tissue maintenance in ageing: focus on biomarkers of bone, cartilage, muscle, and brain tissue maintenance
    Evie van der Spoel, Nicolien A van Vliet, Diana van Heemst · 2019 · Ageing Research Reviews
62. Sclerostin serum levels in patients with systemic autoimmune diseases
    Concepción Fernández-Roldán, Fernanda Genre, Raquel López‐Mejías, Begoña Ubilla, Verónica Mijares, Daniel Sánchez‐Cano, Concepción López Robles, José Luís Callejas-Rubio, Raquel Ríos-Fernández, Manuela Expósito Ruíz et al. · 2016 · BoneKEy Reports
63. Sclerostin, preadipocyte factor-1 and bone mineral values in eumenorrheic adolescent athletes with different training patterns
    Jaak Jürimäe, Vita Karvelyte, Liina Remmel, Anna‐Liisa Tamm, Priit Purge, Rita Gruodytė-Račienė, Sigitas Kamandulis, Katre Maasalu, Luis Gracia‐Marco, Vallo Tillmann · 2020 · Journal of Bone and Mineral Metabolism
64. Relevance of serum sclerostin concentrations in critically ill patients
    Alexander Hemdorff Koch, Ralf Weiskirchen, Sebastian Ludwig, Lukas Buendgens, Jan Bruensing, Eray Yagmur, Christer Baeck, Ulf Herbers, Christian Trautwein, Frank Tacke · 2016 · Journal of Critical Care
65. Sclerostin in excessive drinkers: relationships with liver function and body composition
    Martín González, Candelaria, Fernández Rodríguez, Camino María, Abreu González, Pedro, García Rodríguez, Alen, Alvisa Negrín, Julio César, Cabañas Perales, Elisa, González Navarrete, Lourdes, Vera Delgado, Víctor Eugenio, Ortega Toledo, Paula, González Reimers, Emilio · 2022 · Nutrients
66. Male Runners With Lower Energy Availability Have Impaired Skeletal Integrity Compared to Nonathletes
    Haines, Melanie S, Kaur, Snimarjot, Scarff, Geetanjali, Lauze, Meghan, Gerweck, Anu, Slattery, Meghan, Oreskovic, Nicolas M, Ackerman, Kathryn E, Tenforde, Adam S, Popp, Kristin L et al. · 2023 · The Journal of Clinical Endocrinology & Metabolism
67. Obesity and Bone Loss at Menopause: The Role of Sclerostin
    Paolo Marzullo, Chiara Mele, Stefania Mai, Antonio Nardone, Massimo Scacchi, Gianluca Aimaretti · 2021 · Diagnostics
68. Whole blood viscosity is negatively associated with bone mineral density in postmenopausal women with osteoporosis
    Zongyan Teng, Lichun Pei, Ying Zhang, Ying Li, Ruitao Wang · 2013 · Bone
69. The systemic effects of sclerostin overexpression using ΦC31 integrase in mice
    Dongdong Zhang, Bo Mi Park, Myengmo Kang, Hee Jin Nam, Eun Jin Kim, Chu Hyun Bae, Sung Kil Lim · 2016 · Biochemical and Biophysical Research Communications
70. Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
    Ryan D. Ross, Anjali Sharma, Qiuhu Shi, Donald R. Hoover, Kathleen M. Weber, Phyllis C. Tien, Audrey L. French, Lena Al‐Harthi, Michael T. Yin · 2020 · Bone Reports
71. The Gestational Effects of Maternal Bone Marker Molecules on Fetal Growth, Metabolism and Long-Term Metabolic Health: A Systematic Review
    Angelos Dimas, Anastasia Politi, Αlexandra Bargiota, Theodoros Panoskaltsis, Nikolaos Vlahos, Georgios Valsamakis · 2022 · International Journal of Molecular Sciences
72. Association between Sclerostin and Bone Mineral Density in a Mexican Sample of Women with Rheumatoid Arthritis: A Pilot Study
    Virginia Margarita Vargas-Muñoz, Juan Miguel Jiménez‐Andrade, Jaira Villarreal-Salcido · 2015 · Journal of Arthritis
73. Physical performance and protein-energy wasting in patients treated with nocturnal haemodialysis compared to conventional haemodialysis: protocol of the DiapriFIT study
    Manouk Dam, Floor Neelemaat, Trudeke I. Struijk-Wielinga, Peter J.M. Weijs, Brigit C. van Jaarsveld · 2017 · BMC Nephrology
74. Twelve weeks of a diet and exercise intervention alters the acute bone response to exercise in adolescent females with overweight/obesity
    Nigel Kurgan, Lauren E. Skelly, Izabella A. Ludwa, Panagiota Klentrou, Andrea R. Josse · 2023 · Frontiers in Physiology
75. Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women
    Marion Courtalin, Nicolas Bertheaume, Sammy Badr, Alexandrine During, Daniela Lombardo, Valérie Deken, Bernard Cortet, Aline Clabaut, Julien Paccou · 2023 · International Journal of Molecular Sciences
76. Sex Differences in Bone, Muscle, and Inflammatory Markers and Their Associations with Muscle Performance Variables
    Pragya Sharma Ghimire, Adam C. Eckart, Ibtihal K. Al-Makhzoomy, James Stavitz · 2023 · Sports
77. Serum concentrations of sclerostin and bone turnover markers in children with cow's milk allergy.
    Jadwiga Ambroszkiewicz, Grażyna Rowicka, Magdalena Chełchowska, Joanna Gajewska, Małgorzata Strucińska, Teresa Laskowska–Klita · 2013 · PubMed
78. Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women
    Qun Cheng, Wenjing Tang, Tzong‐Jen Sheu, Yanping Du, Jiemin Gan, Huilin Li, Wei Hong, Xiaoying Zhu, Sihong Xue, Xuemei Zhang · 2016 · Clinica Chimica Acta
79. Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in Taiwan
    Ming‐Shyan Lin, Po‐Han Chen, Po‐Chang Wang, Huang-Shen Lin, Tung‐Jung Huang, Shih‐Tai Chang, Wen‐Nan Chiu, Mei‐Yen Chen · 2019 · BMJ Open
80. Circulating bioactive sclerostin levels in an Austrian population-based cohort
    Katharina Kerschan‐Schindl, Ursula Föger‐Samwald, Andreas Gleiß, Stefan Kudlacek, Jacqueline Wallwitz, Peter Pietschmann · 2021 · Wiener klinische Wochenschrift
81. Associations between Sclerostin and Anthropometric and Metabolic Parameters in Children and Adolescents
    Shin‐Hee Kim, Yun Jung Choi, Moon Bae Ahn, Won Kyoung Cho, Kyoung Soon Cho, Min Ho Jung, Byung‐Kyu Suh · 2021 · Children
82. Plasma sclerostin levels are associated with nutritional status and insulin resistance but not hormonal disturbances in women with polycystic ovary syndrome
    Katarzyna Wyskida, Grzegorz Franik, Aleksander Jerzy Owczarek, Piotr Stanisław Choręza, Piotr Kocełak, Paweł Madej, Jerzy Tadeusz Chudek, Magdalena Olszanecka‐Glinianowicz · 2020 · Archives of Gynecology and Obstetrics
83. The effects of combined amplitude and high-frequency vibration on physically inactive osteopenic postmenopausal women
    Peter Fernandez, Marion Pasqualini, H. Locrelle, Myriam Normand, Christine Bonneau, Marie‐Hélène Lafage‐Proust, Hubert Marotte, Thierry Thomas, Laurence Vico · 2022 · Frontiers in Physiology
84. Impact of Effectiveness of Physical Activity in a Virtual Environment on the Regulation of Sclerostin and Interleukin 6 Levels in Haemodialysis Patients
    Agnieszka Turoń-Skrzypińska, Alicja Mińko, Aleksandra Rył, Katarzyna Mańkowska, Kazimierz Ciechanowski, Zuzanna Bereda, Iwona Rotter, Edward Dutkiewicz · 2024 · Journal of Clinical Medicine
85. Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait
    Tahani Alramah, Preethi Cherian, Irina Al‐Khairi, Mohamed Abu‐Farha, Thangavel Alphonse Thanaraj, Ahmed Najeeb Albatineh, Fayez F. Safadi, Hamad Ali, Muhammad A Abdul‐Ghani, Jaakko O. Tuomilehto et al. · 2024 · Frontiers in Endocrinology
86. Sclerostin Blockade—A Dual Mode of Action After All?
    Ulrike Baschant, Holger Henneicke, Lorenz Christian Hofbauer, Martina Rauner · 2016 · Journal of Bone and Mineral Research
87. Integrated RNA-Seq Analysis Uncovers the Potential Mechanism of the “Kidney Governing Bones” Theory of TCM
    Shuo Yang, Tiancheng Wang, Jingcheng Zhang, Xiangyang Leng, Baojin Yao · 2022 · Evidence-based Complementary and Alternative Medicine
88. Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration
    Martyna Patalong-Wójcik, Anna Golara, Katarzyna Zając, Alicja Sokołowska, Mateusz Kozłowski, Aleksandra Tołoczko‐Grabarek, Mariola Krzyścin, Agnieszka Brodowska, Agnieszka Janiec, Aleksandra Myszka et al. · 2023 · Biomedicines
89. Sclerostin and Dickkopf-1 Characteristics According to Age and Physical Activity Levels in Premenopausal Women
    Pragya Sharma Ghimire, Samuel R. Buchanan, Michael G. Bemben, ALLEN W. KNEHANS, Jason A. Campbell, Debra A. Bemben · 2021 · Journal of Clinical Densitometry
90. Preeclampsia – a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia
    Julia Wild, Petra Pateisky, Lorenz Küssel, Wolfgang Huf, Johannes Ott, Peter Haslinger, Martin Knöfler, Harald Zeisler · 2014 · Hypertension in Pregnancy
91. Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy—Pilot Study
    Agnieszka Turoń-Skrzypińska, Edward Dutkiewicz, Małgorzata Marchelek‐Myśliwiec, Violetta Dziedziejko, Kazimierz Ciechanowski, Aleksandra Rył, Iwona Rotter · 2019 · Medicina
92. Effect of a 3-month L-carnitine supplementation and resistance training program on circulating markers and bone mineral density in postmenopausal women: a randomized controlled trial
    Robert Antoni Olek, Emilia Samborowska, Piotr Wiśniewski, Pawel Wojtkiewicz, Krystian Wochna, Jacek Zieliński · 2023 · Nutrition & Metabolism
93. Serum Sclerostin Levels in Newborns Born to Mothers with Vitamin D Deficiency
    Gonca Sandal, Özgür Pirgon, Bumin Nuri Dündar, Hasan Çetin, Halil Ibrahim Bayram · 2015 · Journal of Investigative Medicine
94. Varying Patterns of Biomarkers of Mineral and Bone Metabolism After Kidney Transplantation
    Agnieszka Makówka, Maciej Głyda, Ewa-Rutkowska Majewska, Michal P. Nowicki · 2017 · Hormone and Metabolic Research
95. Plasma FGF-21 and Sclerostin Levels, Glycemia, Adiposity, and Insulin Sensitivity in Normoglycemic Black and White Adults
    NKIRU A. UMEKWE, Ibiye Owei, Frankie B. Stentz, Samuel E. Dagogo-Jack · 2021 · Journal of the Endocrine Society
96. Disorders of Mineral Metabolism: Normal Homeostasis
    Allen W. Root · 2021 · Elsevier eBooks
97. Relationship Between Osteoporosis and Serum Sclerostin Levels in Kidney Transplant Recipients.
    Hasan Basir, Orçun Altunören, Ertuğrul Erken, Metin Kılınç, Feyza Nur Sarışık, Songül Işiktaş, Özkan Güngör · 2019 · Experimental and Clinical Transplantation
98. Linear and non-linear relationships between body fat mass distribution and bone mineral density in adults: The NHANES, 2011–2018
    Xiaohua Zhang, Juan Zhang, Zhaoyue Shang, Yanlin Duan, Yongliang Du, Bo Kan, Shuman Yang · 2024 · Preventive Medicine
99. Inhibitors of osteoblastogenesis in early human milk and maternal serum: evidence for protective properties of mother’s milk on bone
    Despina D. Briana, Stavroula Gavrili, Sophia Georgantzi, Antonios Marmarinos, Konstantinos A. Voulgaris, Christos Christou, Dimitrios Gourgiotis, Ariadne Malamitsi‐Puchner · 2018 · The Journal of Maternal-Fetal & Neonatal Medicine
100. Serum sclerostin and glucose homeostasis: No association in healthy men. Cross-sectional and prospective data from the EGIR-RISC study
     Jens-Jacob Lauterlein, Anne Pernille Hermann, Thomas Konrad, Peter S. Wolf, Peter Nilsson, Rafael Gabriel Sánchez, Ele Ferrannini, Beverley Balkau, Kurt Højlund, Morten Frost · 2020 · Bone